transverse myelitis

DEFINITION of transverse myelitis

Transverse myelitis is an inflammatory condition affecting a cross-sectional segment of the spinal cord, producing bilateral — though not necessarily symmetric — motor weakness, sensory deficits, and autonomic dysfunction (e.g., bladder, bowel, and sexual dysfunction) below the level of involvement. It is distinguished from Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis by its monophasic presentation, bilateral involvement of the full cord width, and the absence (in idiopathic forms) of optic neuritis or disseminated CNS lesions — though TM may be the presenting event of either condition. The underlying mechanism involves T-cell-mediated autoimmune inflammation targeting myelin and axons within the cord, often triggered by infection, vaccination, or systemic autoimmune disease, leading to demyelination, axonal injury, and secondary edema that disrupts ascending and descending tracts.

Physiologically, TM can be parainfectious (immune-mediated, occurring days to weeks after an infectious illness) or post-infectious (direct viral invasion of cord tissue), and pathologically it is classified as either complete (dense, symmetric deficits) or partial, incomplete, asymmetric deficits — the latter raising concern for MS. Subtypes most relevant to inpatient coding include idiopathic transverse myelitis (G37.3), TM in demyelinating disease of the CNS (G37.3), and TM classified under specific systemic conditions such as SLE (M32.19) or neuromyelitis optica (G36.0). It is commonly confused with Guillain-Barré Syndrome, which involves the peripheral nervous system (ascending, flaccid paralysis, areflexia) rather than the spinal cord, and with spinal cord compression, which is a structural rather than inflammatory etiology.

---

ETYMOLOGY of transverse myelitis

greek | latin

Component	Origin	Meaning
trans-	Latin trans (tranz)	“across,” “through,” “beyond” — directional prefix indicating full cross-sectional involvement
versus (in transverse)	Latin vertere (WER-teh-reh), from versus (to turn)	“turned across,” “crosswise” — describing orientation perpendicular to the long axis
myelo-	Greek myelos (MYE-eh-los)	“marrow,” “spinal cord,” “bone marrow”
-itis	Greek -itis (EYE-tis)	Noun-forming suffix — “inflammation of” — denoting active inflammatory process

The compound entered English in the 1880s as transverse myelitis (noun), constructed from Latin transversus (“lying across,” from trans- + vertere) combined with Greek myelos (“marrow/spinal cord”) and the Greek inflammatory suffix -itis. The root myelos (“marrow”) connects transverse myelitis to the entire myelo- root family: myelopathy (myelo- + -pathy → disease of the spinal cord), myelography (myelo- + -graphy → imaging of the spinal cord), and myeloma (myelo- + -oma → tumor of marrow cells). The directional prefix trans- is highly productive in medical terminology — appearing in transection, transudate, transplant, and transurethral.

---

🔀 ALIASES / ALTERNATE TERMS

• Transverse (adjective form — clinical collocations include “transverse myelitis,” “transverse lesion,” “transverse cord syndrome”)
• ATM (acute transverse myelitis; used in neurology and MS/NMO workup settings to denote first-episode, rapid-onset presentation)
• Partial Transverse Myelitis (incomplete cross-sectional involvement — asymmetric, unilateral or patchy deficits; signals higher risk of conversion to MS; distinguished from complete TM)
• Complete Transverse Myelitis (dense, symmetric bilateral deficits below the lesion level; more often idiopathic or NMO-associated than MS)
• Idiopathic Transverse Myelitis|Idiopathic TM (TM with no identified underlying cause after full workup; coded G37.3; diagnosis of exclusion)
• Parainfectious Myelitis (immune-mediated cord inflammation triggered by recent infection — not direct viral invasion; typically occurs 1-3 weeks post-illness)
• Post-infectious Myelitis (direct viral invasion of cord tissue; distinguished from parainfectious by timing and CSF findings)
• Autoimmune Myelitis (TM attributable to systemic autoimmune disease — SLE, Sjögren’s, antiphospholipid syndrome; coded under the underlying condition)
• Acute Flaccid Myelitis (AFM — enterovirus-associated anterior horn cell involvement; gray matter predominant; distinct entity from classic TM — coded G04.82)
• NMO-Associated Myelitis (longitudinally extensive TM ≥3 vertebral segments; hallmark of neuromyelitis optica spectrum disorder — G36.0)
• MS-Associated Myelitis (short-segment, asymmetric/partial TM; first demyelinating event in MS workup — G35.D)

---

🔗 RELATED TERMS

• Myelopathy — the opposite of inflammatory origin; refers to any functional disturbance of the spinal cord, most commonly from compression (M47.816-M47.817) or ischemia — distinguished from TM by etiology (structural/vascular vs. inflammatory) and MRI signal pattern
• encephalomyelitis — shares the myelo- root; inflammation involving both the brain and spinal cord simultaneously; the “myelitis” component may be indistinguishable from TM without neuroimaging of both regions
• Neuromyelitis Optica Spectrum Disorder — closely related clinical entity ([[G36.0]]) — TM is the defining spinal cord manifestation; presence of AQP4-IgG or MOG-IgG antibodies distinguishes NMO-associated TM from idiopathic TM
• Multiple Sclerosis — (G35.D) — partial, short-segment TM is a common MS relapse phenotype; full TM workup includes McDonald criteria assessment to exclude MS
• Demyelination — primary pathological mechanism underlying TM in most idiopathic and MS/NMO-associated cases; loss of myelin sheath disrupts saltatory conduction in ascending and descending tracts
• Inflammatory — adjective describing the immune-mediated process (T-cell infiltration, cytokine release, blood-brain barrier disruption) that sustains cord injury in TM
• apoptosis — programmed cell death of oligodendrocytes and neurons underlying both physiological remyelination failure and irreversible cord injury in severe TM
• Acute Disseminated Encephalomyelitis (ADEM) — (G04.00) — post-infectious multifocal demyelinating disease that may include a TM component; defined by multiphasic CNS involvement, distinguishing it from isolated TM
• Acute Flaccid Myelitis (AFM) — (G04.82) — enterovirus D68/A71-associated anterior horn disease resembling polio; shares acute onset with TM but is gray-matter predominant and lacks sensory level
• Spinal Cord Compression — structural mimic of TM; caused by disc herniation, epidural abscess, or malignancy — excluded before TM diagnosis by urgent MRI with contrast
• Systemic Lupus Erythematosus with CNS Involvement — (M32.19) — SLE-associated myelitis is coded under the underlying disease and represents one of the most important secondary causes of TM in women of childbearing age
• MRI Spine with and without Contrast — primary diagnostic tool for evaluating TM; T2 hyperintensity spanning ≥3 vertebral segments suggests NMO; short-segment asymmetric lesion suggests MS

---

CODING CORNER

🏥 ICD-10-CM CODES

Demyelinating Diseases of CNS | Transverse Myelitis & Myelopathy (G37.x)

Code	Description
G37.3	Acute transverse myelitis in demyelinating disease of central nervous system
**	G04.89**

Neuromyelitis Optica Spectrum Disorder

Code	Description
G36.0	Neuromyelitis optica Devic — use when TM is NMO-associated with AQP4-IgG or MOG-IgG positivity

Viral Myelitis / Infectious Etiology

Code	Description
G04.02	Postimmunization acute disseminated encephalitis, myelitis, and encephalomyelitis
G04.82	Acute flaccid myelitis (AFM — enterovirus-associated; anterior horn disease)
G04.01	Postinfectious acute disseminated encephalitis, myelitis, and encephalomyelitis
G04.00	Acute disseminated encephalomyelitis, unspecified

Multiple Sclerosis | TM as Initial/Relapsing Presentation

Code	Description
G35.D	Multiple sclerosis — use when partial TM is confirmed as an MS relapse or CIS converting to MS

Autoimmune / Secondary Etiologies

Code	Description
M32.19	Other organ or system involvement in systemic lupus erythematosus (CNS/myelitis)
M35.09	Other sicca syndrome [Sjögren] — when myelitis is a CNS manifestation of Sjögren’s
G99.2	Myelopathy in diseases classified elsewhere — use with underlying cause as principal Dx when cord dysfunction is a manifestation

Residual / Sequela Coding

Code	Description
G83.4	Cauda equina syndrome — if TM lesion at conus/cauda level produces bladder/bowel/sexual dysfunction
R33.9	Retention of urine, unspecified — neurogenic bladder sequela when not further specified
G95.89	Other specified diseases of spinal cord — residual myelopathy when acute phase has resolved

---

🔧 COMMON CPT CODES (Transverse Myelitis-Related Diagnosis & Treatment)

CPT Code	Description
62270	Spinal puncture, lumbar, diagnostic — CSF analysis essential to TM workup (cell count, protein, oligoclonal bands, NMO-IgG)
72148	MRI spinal canal and contents, lumbar; without contrast
72149	MRI spinal canal and contents, lumbar; with contrast
72156	MRI spinal canal and contents, cervical; with contrast — primary imaging for cervical TM
72157	MRI spinal canal and contents, thoracic; with contrast — primary imaging for thoracic TM (most common segment)
72158	MRI spinal canal and contents, lumbar; with contrast
86255	Fluorescent antibody; screen, each antibody — AQP4-IgG (NMO antibody) testing
86596	Antinuclear antibodies (ANA) — systemic autoimmune workup for secondary TM etiology
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour — high-dose IV methylprednisolone (IVMP) induction
97110	Therapeutic exercises, each 15 minutes — to develop strength, endurance, ROM in TM rehabilitation
97530	Therapeutic activities, each 15 minutes — functional mobility retraining in acute TM rehab

---

⚠️ Coding Note: G37.3 requires documented demyelinating disease of the CNS as the context for TM — if the etiology is unknown or workup is incomplete at discharge, G04.89 (other myelitis) may be more accurate and should be queried if documentation is ambiguous. Sequencing follows etiology: when TM is a manifestation of SLE (M32.19), MS (G35.x), or NMO (G36.0), sequence the underlying condition as principal diagnosis and TM as an additional code per manifestation coding guidelines (instructional note at G99.2 applies). A critical undercoding alert: neurogenic bladder and urinary retention are extremely common TM sequelae and are frequently documented only as “bladder dysfunction” — query the physician for specificity (N31.9 neurogenic bladder, R33.9 urinary retention) as these may affect DRG assignment and support medical necessity for foley or intermittent catheterization. For inpatient profee claims involving IV steroid infusion, verify that the administering provider’s role is documented to support the infusion administration code (96413). When TM occurs in the context of a documented autoimmune disease, payers including UHC and Aetna may require an AQP4-IgG and MOG-IgG result in the record to authorize biologics (e.g., eculizumab, inebilizumab) for NMO-associated TM going forward.

---

DERIVATIONS of transverse myelitis

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[transverse myelitis]].roots, word))) > 0 AND file.name != [[transverse myelitis]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[transverse myelitis]].definition, word))) > 0 AND file.name != [[transverse myelitis]].file.name

Med roots dictionary Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms